Literature DB >> 6402777

Immunoglobulin gene expression in transformed lymphoid cells.

V T Oi, S L Morrison, L A Herzenberg, P Berg.   

Abstract

Myeloma, hybridoma, and thymoma cell lines have been successfully transfected for the Escherichia coli xanthine-guanine phosphoribosyltransferase gene (gpt) by using the plasmid vector pSV2-gpt. The transformed cells synthesize the bacterial enzyme 5-phospho-alpha-D-ribose-1-diphosphate:xanthine phosphoribosyltransferase (XGPRT; EC 2.4.2.22) and have been maintained in selective medium for over 4 months. Lymphoid cell lines expressing a K immunoglobulin light chain were obtained by transfecting cells with pSV2-gpt containing a rearranged K light chain genomic segment from the S107 myeloma cell line. The S107 light chain is synthesized in gpt-transformed J558L myeloma cells and is identical to the light chain synthesized by the S107 myeloma cell line, as judged by immunoprecipitation and two-dimensional gel electrophoresis. Furthermore, this light chain is synthesized and secreted as part of an intact antibody molecule by transformed hybridoma cells that normally secrete an IgGl (gamma, K) antibody molecule. No light chain synthesis was detected in a similarly transformed rat myeloma or a mouse thymoma line.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6402777      PMCID: PMC393473          DOI: 10.1073/pnas.80.3.825

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  26 in total

1.  Letter: Fusion of two immunoglobulin-producing myeloma cells.

Authors:  R G Cotton; C Milstein
Journal:  Nature       Date:  1973-07-06       Impact factor: 49.962

2.  Suppression of immunoglobulin synthesis by cellular hybridization.

Authors:  P Coffino; B Knowles; S G Nathenson; M D Scharff
Journal:  Nat New Biol       Date:  1971-05-19

3.  A new technique for the assay of infectivity of human adenovirus 5 DNA.

Authors:  F L Graham; A J van der Eb
Journal:  Virology       Date:  1973-04       Impact factor: 3.616

4.  Immunochemical studies on mouse myeloma proteins with specificity for dextran or for levan.

Authors:  A Lundblad; R Steller; E A Kabat; J W Hirst; M G Weigert; M Cohn
Journal:  Immunochemistry       Date:  1972-05

5.  Properties of monoclonal antibodies to mouse Ig allotypes, H-2, and Ia antigens.

Authors:  V T Oi; P P Jones; J W Goding; L A Herzenberg; L A Herzenberg
Journal:  Curr Top Microbiol Immunol       Date:  1978       Impact factor: 4.291

6.  Detection of specific hybridoma clones by replica immunoadsorption of their secreted antibodies.

Authors:  J Sharon; S L Morrison; E A Kabat
Journal:  Proc Natl Acad Sci U S A       Date:  1979-03       Impact factor: 11.205

7.  Rat x rat hybrid myelomas and a monoclonal anti-Fd portion of mouse IgG.

Authors:  G Galfrè; C Milstein; B Wright
Journal:  Nature       Date:  1979-01-11       Impact factor: 49.962

8.  Characterization of a spontaneous murine B cell leukemia (BCL1). II. Tumor cell proliferation and IgM secretion after stimulation by LPS.

Authors:  M R Knapp; E Severinson-Gronowicz; J Schröder; S Strober
Journal:  J Immunol       Date:  1979-09       Impact factor: 5.422

9.  Rabbit beta-globin mRNA production in mouse L cells transformed with cloned rabbit beta-globin chromosomal DNA.

Authors:  N Mantei; W Boll; C Weissmann
Journal:  Nature       Date:  1979-09-06       Impact factor: 49.962

10.  Lymphocyte membrane IgG and secreted IgG are structurally and allotypically distinct.

Authors:  V T Oi; V M Bryan; L A Herzenberg; L A Herzenberg
Journal:  J Exp Med       Date:  1980-05-01       Impact factor: 14.307

View more
  129 in total

1.  Assembly requirements of PU.1-Pip (IRF-4) activator complexes: inhibiting function in vivo using fused dimers.

Authors:  A L Brass; A Q Zhu; H Singh
Journal:  EMBO J       Date:  1999-02-15       Impact factor: 11.598

2.  The serine and threonine residues in the Ig-alpha cytoplasmic tail negatively regulate immunoreceptor tyrosine-based activation motif-mediated signal transduction.

Authors:  R Müller; J Wienands; M Reth
Journal:  Proc Natl Acad Sci U S A       Date:  2000-07-18       Impact factor: 11.205

Review 3.  The second century of the antibody. Molecular perspectives in regulation, pathophysiology, and therapeutic applications.

Authors:  J Braun; A Saxon; R Wall; S L Morrison
Journal:  West J Med       Date:  1992-08

4.  High-level production of a functional immunoglobulin heterodimer in a baculovirus expression system.

Authors:  C A Hasemann; J D Capra
Journal:  Proc Natl Acad Sci U S A       Date:  1990-05       Impact factor: 11.205

5.  Parameters that govern the regulation of immunoglobulin delta heavy-chain gene expression.

Authors:  R Tisch; N Kondo; N Hozumi
Journal:  Mol Cell Biol       Date:  1990-10       Impact factor: 4.272

6.  The immunoglobulin heavy-chain enhancer functions as the promoter for I mu sterile transcription.

Authors:  L K Su; T Kadesch
Journal:  Mol Cell Biol       Date:  1990-06       Impact factor: 4.272

7.  Interaction of a nuclear protein with a palindromic sequence of the mouse immunoglobulin lambda 2-chain gene promoter is important for its transcription.

Authors:  L A Chang; H Murialdo
Journal:  Mol Cell Biol       Date:  1990-11       Impact factor: 4.272

8.  A differentially expressed murine RNA encoding a protein with similarities to two types of nucleic acid binding motifs.

Authors:  M Ayane; U Preuss; G Köhler; P J Nielsen
Journal:  Nucleic Acids Res       Date:  1991-03-25       Impact factor: 16.971

9.  Enhancer-dependent expression of human kappa immunoglobulin genes introduced into mouse pre-B lymphocytes by electroporation.

Authors:  H Potter; L Weir; P Leder
Journal:  Proc Natl Acad Sci U S A       Date:  1984-11       Impact factor: 11.205

10.  Generation of antibody activity from immunoglobulin polypeptide chains produced in Escherichia coli.

Authors:  S Cabilly; A D Riggs; H Pande; J E Shively; W E Holmes; M Rey; L J Perry; R Wetzel; H L Heyneker
Journal:  Proc Natl Acad Sci U S A       Date:  1984-06       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.